Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2009
08/26/2009EP2093207A1 Antiinfective and antitumoral compounds isolated from tropical lianas
08/26/2009EP2092941A2 Drug releasing coatings for medical devices
08/26/2009EP2092936A2 Tamper-resistant oral opioid agonist formulations
08/26/2009EP2092935A1 Pharmaceutical compositions for the treatment of asthma
08/26/2009EP2092834A1 Methods and compositions of sphingolipid for preventing treating microbial infections
08/26/2009EP2092080A1 Diagnosis and treatment of t-cell acute lymphoblastic leukemia
08/26/2009EP2092065A1 Antisense compounds
08/26/2009EP2092055A1 Novel vitamin d2 yeast preparation, a method for producing the same, and the use thereof
08/26/2009EP2091960A2 Peptide vaccine for influenza virus
08/26/2009EP2091955A1 Alkoxy compounds for disease treatment
08/26/2009EP2091953A1 8-sulfonyl-l, 3, 4, 8-tetrahydr0-2h- [1, 4]oxazepino [6, 7-e]indole derivatives and their use as 5-ht6 receptor ligands
08/26/2009EP2091952A1 Pyrazolo ý3, 4 -d¨pyrimidine p38 map kinase inhibitors
08/26/2009EP2091951A2 Pyrido[2,3-b]pyrazine and[1,8]-naphtyridine derivatives as alk and c-met inhibitors
08/26/2009EP2091950A1 Oxadiazole derivatives as s1p1 receptor agonists
08/26/2009EP2091949A1 Indole derivatives as s1p1 receptor agonists
08/26/2009EP2091948A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091947A2 Glucokinase activators
08/26/2009EP2091946A1 Piperidine derivative used for treating chemokine receptor 5 mediated diseases
08/26/2009EP2091945A1 Novel inhibitors of glutaminyl cyclase
08/26/2009EP2091944A2 Substituted bicyclocarboxyamide compounds
08/26/2009EP2091943A2 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
08/26/2009EP2091942A1 Substituted pyrazinone derivatives for use as a medicine
08/26/2009EP2091941A2 Mapk/erk kinase inhibitors
08/26/2009EP2091939A1 Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition
08/26/2009EP2091938A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
08/26/2009EP2091936A1 Therapeutic agents useful for treating pain
08/26/2009EP2091935A2 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
08/26/2009EP2091933A1 Dihydrobenzofuranyl derivatives and methods of their use
08/26/2009EP2091928A2 3-(2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
08/26/2009EP2091927A1 Thiazole and oxazole-substituted arylamides
08/26/2009EP2091926A1 Substituted pyrazole and triazole compounds as ksp inhibitors
08/26/2009EP2091925A1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same
08/26/2009EP2091922A2 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
08/26/2009EP2091920A2 Substituted pyrazoles, compositions containing these, method of production and use
08/26/2009EP2091919A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer
08/26/2009EP2091917A1 Ion channel modulators
08/26/2009EP2091915A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties
08/26/2009EP2091910A1 Crystalline forms of ( 3 s ) -3- [n- (n' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluoro phenoxy) -4-0x0penta noic acid
08/26/2009EP2091909A1 Water-soluble prodrugs of florfenicol and its analogs
08/26/2009EP2091904A1 New class of terpene-derived compounds having an antibiotic activity, compositions containing the same ans uses thereof
08/26/2009EP2091578A2 Processes to prepare antimicrobial contact lenses
08/26/2009EP2091566A1 Combination treatments for alzheimer's disease and similar diseases
08/26/2009EP2091557A2 Improved methods and compositions for wound healing
08/26/2009EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression
08/26/2009EP2091543A1 Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate
08/26/2009EP2091542A1 Novel use of inhibitors of soluble epoxide hydrolase
08/26/2009EP2091541A1 Vaginal delivery system for mirtazapine
08/26/2009EP2091540A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain.
08/26/2009EP2091539A1 Ambrisentan combined with a renin inhibitor for hypertensive disorder
08/26/2009EP2091538A2 4-benzyl-l(2h)-phthalazinones as h1 receptor antagonists
08/26/2009EP2091537A1 Pharmaceutical compositions for the treatment of capillary arteriopathy
08/26/2009EP2091536A2 Enantiomeric compounds with antibacterial activity
08/26/2009EP2091535A1 Use of pkc inhibitors in transplantation
08/26/2009EP2091534A1 Azetidinone derivatives and methods of use thereof
08/26/2009EP2091533A1 Constrained spirocyclic compounds as cgrp receptor antagonists
08/26/2009EP2091532A1 Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
08/26/2009EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
08/26/2009EP2091530A1 Composition for inhibiting nadph oxidase activity
08/26/2009EP2091529A1 Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases
08/26/2009EP2091528A2 Methods of inactivating viruses
08/26/2009EP2091527A2 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
08/26/2009EP2091526A1 Treatment of pervasive developmental disorders
08/26/2009EP2091525A1 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors
08/26/2009EP2091524A2 Combination therapy for treating hepatitis c infections
08/26/2009EP2091523A1 Anandamide
08/26/2009EP2091522A1 Nutritional supplement composition for treatment of ocular diseases
08/26/2009EP2091521A1 Anticonvulsive pharmaceutical compositions
08/26/2009EP2091520A1 Oral dosage form comprising tri-substituted glycerol compounds
08/26/2009EP2091517A2 Materials and methods of introducing genetic material into living cells
08/26/2009EP2091329A1 Indazole compounds
08/26/2009EP2091328A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2009EP2091325A2 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
08/26/2009EP2091320A2 Sorption medium
08/26/2009EP2026821B1 Hyaluronic acid binary mixtures and therapeutic use thereof
08/26/2009EP1993526A4 Epinephrine dosing regimens
08/26/2009EP1987026B1 Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders
08/26/2009EP1981878B1 Indazole heteroaryl derivatives
08/26/2009EP1940245B1 Method for treating and/or preventing infections in infants delivered via caesarean section
08/26/2009EP1911746B1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof
08/26/2009EP1904484B1 Compounds
08/26/2009EP1861105B1 Process for the preparation of galanthamine hydrobromide
08/26/2009EP1858898B1 Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use
08/26/2009EP1856125B1 Protease inhibitor precursor synthesis
08/26/2009EP1835912B1 Substituted benzimidazoles for treatment of histomoniasis
08/26/2009EP1819693B1 Antithrombotic diamides
08/26/2009EP1789429B1 Bifunctional antibiotics for targeting rrna and resistance causing enzymes and for inhibition of anthrax lethal factor
08/26/2009EP1781097A4 Liver disease-related methods and systems
08/26/2009EP1773817B1 Substituted aryl-amine derivatives and methods of use
08/26/2009EP1756071B1 Benzoxazolone derivatives, processes for preparing them and their uses
08/26/2009EP1752155A4 Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions
08/26/2009EP1745033A4 4,5-disubstituted-2-aryl pyrimidines
08/26/2009EP1744732A4 Nutritional composition for increasing creatine uptake in skeletal muscle
08/26/2009EP1732525B1 Amorolfine patch for treating onychomycosis
08/26/2009EP1711200A4 Type ii diabetes
08/26/2009EP1701947B1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof
08/26/2009EP1694676B1 Spiroindoline derivatives having insecticidal properties
08/26/2009EP1677772B1 Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action
08/26/2009EP1631569B1 Quinuclidine derivatives binding to mucarinic m3 receptors
08/26/2009EP1603910B1 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
08/26/2009EP1603899B1 Heterocyclic urea derivatives for the treatment of pain
1 ... 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 ... 7860